Triplebar and Umami Meats Initiate Technology Collaboration To Optimize Cell Lines for Sustainable Seafood
- Biotechnology company Triplebar and cultivated seafood platform company Umami Meats signed a letter of intent to collaborate on development of cell lines for sustainable cultivated seafood – starting with Japanese eel
- Together, teams will improve the fitness and performance of cell lines to enable lower-cost, more efficient production of cultivated fish, reducing supply-chain risks, and relieving pressure on decimated fish stocks
- An increasingly popular ingredient for sushi and other Japanese dishes, eels are critically endangered in the wild, and eel aquaculture is unsustainable due to reliance on wild-caught glass eels
Excerpt from the Press Release:
EMERYVILLE, Calif. & SINGAPORE–(BUSINESS WIRE)–Biotechnology company Triplebar and cultivated seafood platform company Umami Meats are partnering to co-develop optimized cell lines suitable for large-scale production of cultivated seafood – starting with one of the most popular and critically endangered fish species.
Emeryville, Calif.-based Triplebar and Singapore-headquartered Umami Meats signed a letter of intent this month to collaborate on shared technical milestones, with the unified mission of producing commercially viable, scalable, and affordable cultivated seafood. Their first project will be Japanese eel.
Together, Triplebar and Umami teams will work to improve the fitness and performance of cell lines to enable lower-cost, more efficient production of cultivated foods. The shared goal is to reduce the cost of high-quality foods, reduce supply-chain risks in the global fishing and aquaculture industry, and relieve pressure on depleted fish stocks in the world’s oceans.
Click the button below to read the entire Press Release:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?